Contract Pharma Manufacturing Solutions

  1. Cleanroom Capabilities And Expertise

    Learn how the right partner can ensure that your facilities maintain cGMP-compliance and help establish the correct testing program and parameters based on your needs.

  2. The Power Of Two, The Ease Of One: Two Experts, One Streamlined Solution 12/10/2025

    A strategic alliance accelerates the delivery of complex bioconjugates by integrating the entire drug substance and drug product manufacturing process into one streamlined solution.

  3. Large Molecule Expertise. Ingenuity You Can Count On. 7/30/2024

    As a fully integrated CDMO, we offer a comprehensive suite of services, from early-stage research to robust commercial manufacturing, within our state-of-the-art facilities.

  4. Contract Drug Development, Manufacturing, And Analytical Testing 1/29/2024

    Explore our collection of capabilities, including liquid-filled capsules, band/sealing technologies, powder, over-encapsulated capsules, topical formulations, and clinical and blister packaging.

  5. A Technology-Driven CDMO Delivering Integrated End-To-End Services

    Explore this interactive PDF with information about technologies & end-to-end integrated CDMO services provided by Adare Pharma Solutions.

  6. mRNA Development And Manufacturing Services 8/17/2026

    Our end-to-end mRNA CDMO platform covers synthesis, LNP formulation, fill-finish, and QC under one roof — from early clinical to commercial scale-up to 100g.

  7. Exceptional Fill/Finish Flexibility — The Right Scale At The Right Time 10/25/2023

    Leveraging a CDMO's expertise and facilities to support high-speed filling for vials and bottles, prefilled syringes, and flexible IV bags can help meet project milestones and deliver treatments to patients in need.

  8. Valladolid: Site Capabilities Overview 2/18/2026

    Backed by strong regulatory expertise and a track record of global inspections, the Valladolid site delivers reliable, compliant solutions for pharmaceutical partners seeking end-to-end development and manufacturing support.

  9. Advancing CRISPR-Based Therapeutic Development 5/5/2026

    A CDMO that manufactures nucleases at research and cGMP grades can eliminate the need for custom manufacturing runs, simplify the transition to clinical application, and reduce regulatory paperwork.

  10. Bending The AAV Manufacturing Cost Curve: Scalable Platform Innovation And Productivity Gains 9/9/2026

    A stable producer cell line platform designed to replace transient transfection in AAV manufacturing, offering 10 to 15-fold titer improvements and simplified workflows from development through commercial scale.